Hiroomi Nakatsu

Suggest Changes
Learn More
AIM To examine the efficiency of alpha1-blocker treatment on disease-specific and generic quality of life (QOL) in men with clinically diagnosed benign prostatic hyperplasia (BPH), the improvement of(More)